Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study
Massimiliano Ortore, Elisa Grazioli, Eliana Tranchita, Carlo Minganti, Alessia Manteca, Ludovico Tinto, Claudia Cerulli, Igino Fabi, Antonella Foti, Giovanna Borriello, Paolo Riondino, Attilio Parisi
International Journal of Translational Medicine, doi:10.3390/ijtm2020022
Background: In the last two years, the COVID-19 pandemic has spread all over the world, affecting millions of people. The same infection can manifest in different clinical conditions, ranging from mild situations to severe patient impairment, up to their death. The COVID-19 infection can activate innate and adaptive immune systems and cause massive inflammatory responses that is important to treat as soon as possible. Methods: In the initial phase of the pandemic, a group of 240 unvaccinated subjects with COVID-19 disease was administered phytotherapy with immunostimulant and antioxidant property to evaluate the role of this phytotherapeutic preparation in counteracting the progression of the COVID-19 disease both in duration and complexity. Results: 161 patients were treated with phytotherapy alone and the prevailing symptoms in the acute phase were rhinitis, fever, cough, osteo-muscular pains; the other 79 patients were given a therapy with NSAIDs, symptomatic drugs, monoclonal antibodies, corticosteroids, antibiotics, and/or heparin. The coexistence of comorbidity (such as diabetes, hypertension, gastro-intestinal disease) was recorded in 74 out of 240 subjects, more frequently in the older subjects; there was no statistically significant correlation between the presence of comorbidity and the duration of disease. Hospitalization rate in this population was 1.6% and lethality rate was 0%. Conclusion: The use of phytotherapy can represent a valid weapon against COVID-19, since it showed no side effects and can also be used in association with other pharmacological therapies to reduce the massive inflammatory responses of this infection.
References
Albassam, Markowitz, An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis), Planta Medica,
doi:10.1055/s-0043-100934Amr, Abo-Ghalia, Moustafa, Al-Omar, Nossier et al., Design, synthesis and docking studies of novel macrocyclic pentapeptides as anticancer multi-targeted kinase inhibitors, Molecules,
doi:10.3390/molecules23102416Andres, Pevny, Ziegenhagen, Bakhiya, Schäfer et al., Safety Aspects of the Use of Quercetin as a Dietary Supplement, Mol. Nutr. Food Res,
doi:10.1002/mnfr.201700447Anka, Tahir, Abubakar, Alsabbagh, Zian et al., Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management, Scand. J. Immunol
Attia, Alagawany, Farag, Alkhatib, Khafaga et al., Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus, Front. Veter. Sci,
doi:10.3389/fvets.2020.573159Brglez Mojzer, Knez Hrnčič, Škerget, Knez, Bren, Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects, Molecules,
doi:10.3390/molecules21070901Chen, Zhang, Zhu, Liu, Chen et al., Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro, Medicine,
doi:10.1097/MD.0000000000022241Chourasia, Koppula, Battu, Ouseph, Singh et al., a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection, Molecules,
doi:10.3390/molecules26051200Dabeek, Marra, Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans, Nutrients,
doi:10.3390/nu11102288Derosa, Maffioli, D'angelo, Di Pierro, A role for quercetin in coronavirus disease 2019 (COVID-19), Phytother. Res,
doi:10.1002/ptr.6887Diniz, Souza, Duarte, De Sousa, Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury, Molecules,
doi:10.3390/molecules25235772Eisvand, Tajbakhsh, Seidel, Zirak, Tabeshpour et al., Quercetin and its role in modulating endoplasmic reticulum stress: A review, Phytother. Res,
doi:10.1002/ptr.7283Gao, Ding, Dong, Zhang, Azkur et al., Risk factors for severe and critically ill COVID-19 patients: A review, Allergy,
doi:10.1111/all.14657Gerotziafas, Catalano, Colgan, Pecsvarady, Wautrecht et al., Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine, Thromb. Haemost,
doi:10.1055/s-0040-1715798Gu, Zhang, Cen, Wu, Lu et al., Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study, PLoS ONE
Hu, Webster, Cao, Shao, The safety of green tea and green tea extract consumption in adults -Results of a systematic review, Regul. Toxicol. Pharmacol,
doi:10.1016/j.yrtph.2018.03.019Hussain, Mahawar, Xia, Yang, El-Hasani et al., Obesity and mortality of COVID-19. Meta-analysis, Obes. Res. Clin. Pract,
doi:10.1016/j.orcp.2020.07.002Kandeil, Mostafa, Kutkat, Moatasim, Al-Karmalawy et al., Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2, Pathogens,
doi:10.3390/pathogens10060758Lesser, Cermak, Wolffram, Bioavailability of Quercetin in Pigs Is Influenced by the Dietary Fat Content, J. Nutr,
doi:10.1093/jn/134.6.1508Luca, Macovei, Bujor, Miron, Skalicka-Woźniak et al., Bioactivity of dietary polyphenols: The role of metabolites, Crit. Rev. Food Sci. Nutr,
doi:10.1080/10408398.2018.1546669Marin, Aghagoli, Lavine, Yang, Siff et al., Predictors of COVID -19 severity: A literature review, Rev. Med. Virol,
doi:10.1002/rmv.2146Marinella, Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19, Int. J. Clin. Pract,
doi:10.1111/ijcp.13535Mhatre, Srivastava, Naik, Patravale, Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review, Phytomedicine,
doi:10.1016/j.phymed.2020.153286O'driscoll, Dos Santos, Wang, Cummings, Azman et al., Age-specific mortality and immunity patterns of SARS-CoV-2, Nature,
doi:10.1038/s41586-020-2918-0Okamoto, Safety of quercetin for clinical application, Int. J. Mol. Med
Pandey, Rane, Chatterjee, Kumar, Khan et al., Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development, J. Biomol. Struct. Dyn
Prasansuklab, Theerasri, Rangsinth, Sillapachaiyaporn, Chuchawankul et al., Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection, J. Tradit. Complement. Med,
doi:10.1016/j.jtcme.2020.12.001Sapra, Bhardwaj, Azam, Madhry, Verma et al., Phytotherapy for treatment of cytokine storm in COVID-19, Front. Biosci,
doi:10.52586/4924Shohan, Nashibi, Mahmoudian-Sani, -R.; Abolnezhadian, Ghafourian et al., The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial, Eur. J. Pharmacol,
doi:10.1016/j.ejphar.2021.174615Stravalaci, Pagani, Paraboschi, Pedotti, Doni et al., Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules, Nat. Immunol,
doi:10.1038/s41590-021-01114-wTo, Sridhar, Chiu, Hung, Li et al., Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic, Emerg. Microbes Infect,
doi:10.1080/22221751.2021.1898291Türsen, Türsen, Lotti, Cutaneous sıde-effects of the potential COVID-19 drugs, Dermatol. Ther,
doi:10.1111/dth.13476Wang, Heber, Henning, Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo, Food Funct,
doi:10.1039/c2fo10254dYin, Wang, Yu, Chen, Zhu et al., Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway, Front. Pharmacol,
doi:10.3389/fphar.2021.716672Younes, Aggett, Aguilar, Crebelli, Dusemund et al., Scientific opinion on the safety of green tea catechins, EFSA J,
doi:10.2903/j.efsa.2018.5239Zhang, Zhang, Bi, He, Yan et al., Potential protective mechanisms of green tea polyphenol EGCG against COVID-19, Trends Food Sci. Technol,
doi:10.1016/j.tifs.2021.05.023{ 'indexed': {'date-parts': [[2022, 6, 17]], 'date-time': '2022-06-17T07:41:39Z', 'timestamp': 1655451699885},
'reference-count': 53,
'publisher': 'MDPI AG',
'issue': '2',
'license': [ { 'start': { 'date-parts': [[2022, 6, 16]],
'date-time': '2022-06-16T00:00:00Z',
'timestamp': 1655337600000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>Background: In the last two years, the COVID-19 pandemic has spread all over the '
'world, affecting millions of people. The same infection can manifest in different clinical '
'conditions, ranging from mild situations to severe patient impairment, up to their death. The '
'COVID-19 infection can activate innate and adaptive immune systems and cause massive '
'inflammatory responses that is important to treat as soon as possible. Methods: In the '
'initial phase of the pandemic, a group of 240 unvaccinated subjects with COVID-19 disease was '
'administered phytotherapy with immunostimulant and antioxidant property to evaluate the role '
'of this phytotherapeutic preparation in counteracting the progression of the COVID-19 disease '
'both in duration and complexity. Results: 161 patients were treated with phytotherapy alone '
'and the prevailing symptoms in the acute phase were rhinitis, fever, cough, osteo-muscular '
'pains; the other 79 patients were given a therapy with NSAIDs, symptomatic drugs, monoclonal '
'antibodies, corticosteroids, antibiotics, and/or heparin. The coexistence of comorbidity '
'(such as diabetes, hypertension, gastro-intestinal disease) was recorded in 74 out of 240 '
'subjects, more frequently in the older subjects; there was no statistically significant '
'correlation between the presence of comorbidity and the duration of disease. Hospitalization '
'rate in this population was 1.6% and lethality rate was 0%. Conclusion: The use of '
'phytotherapy can represent a valid weapon against COVID-19, since it showed no side effects '
'and can also be used in association with other pharmacological therapies to reduce the '
'massive inflammatory responses of this infection.</jats:p>',
'DOI': '10.3390/ijtm2020022',
'type': 'journal-article',
'created': {'date-parts': [[2022, 6, 17]], 'date-time': '2022-06-17T05:48:12Z', 'timestamp': 1655444892000},
'page': '242-251',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy '
'in Patients Suffering from COVID-19 Infection: An Observational Pilot Study',
'prefix': '10.3390',
'volume': '2',
'author': [ {'given': 'Massimiliano', 'family': 'Ortore', 'sequence': 'first', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-4245-1320',
'authenticated-orcid': False,
'given': 'Elisa',
'family': 'Grazioli',
'sequence': 'additional',
'affiliation': []},
{'given': 'Eliana', 'family': 'Tranchita', 'sequence': 'additional', 'affiliation': []},
{'given': 'Carlo', 'family': 'Minganti', 'sequence': 'additional', 'affiliation': []},
{'given': 'Alessia', 'family': 'Manteca', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ludovico', 'family': 'Tinto', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-2637-7968',
'authenticated-orcid': False,
'given': 'Claudia',
'family': 'Cerulli',
'sequence': 'additional',
'affiliation': []},
{'given': 'Igino', 'family': 'Fabi', 'sequence': 'additional', 'affiliation': []},
{'given': 'Antonella', 'family': 'Foti', 'sequence': 'additional', 'affiliation': []},
{'given': 'Giovanna', 'family': 'Borriello', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-8901-0501',
'authenticated-orcid': False,
'given': 'Paolo',
'family': 'Riondino',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-2648-8406',
'authenticated-orcid': False,
'given': 'Attilio',
'family': 'Parisi',
'sequence': 'additional',
'affiliation': []}],
'member': '1968',
'published-online': {'date-parts': [[2022, 6, 16]]},
'reference': [ { 'key': 'ref1',
'unstructured': 'Latest Data OMS Source Health Emergency Dashboard\n'
'https://covid19.who.int'},
{'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/acs.molpharmaceut.0c00608'},
{'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/22221751.2021.1898291'},
{'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.33549/physiolres.934492'},
{'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/sji.12998'},
{'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.orcp.2020.07.002'},
{'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jdiacomp.2020.107817'},
{'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/rmv.2146'},
{'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-020-01202-8'},
{'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/all.14657'},
{'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/pathogens10060758'},
{'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/07391102.2020.1796811'},
{'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fvets.2020.573159'},
{'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.bcab.2021.102179'},
{'key': 'ref15'}, {'key': 'ref16'},
{'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/cells10020206'},
{'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.52586/4924'},
{'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cell.2021.02.029'},
{'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.arcmed.2020.09.010'},
{'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6887'},
{'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules25235772'},
{'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.tifs.2021.05.023'},
{'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules23102416'},
{'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.pharmthera.2020.107613'},
{'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/ijcp.13535'},
{'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.phymed.2020.153286'},
{'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/MD.0000000000022241'},
{'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.7283'},
{'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0245209'},
{'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jn/130.8.2073S'},
{ 'key': 'ref32',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.freeradbiomed.2004.01.002'},
{'key': 'ref33', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu11102288'},
{'key': 'ref34', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/10408398.2018.1546669'},
{'key': 'ref35', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jn/134.6.1508'},
{'key': 'ref36', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules21070901'},
{'key': 'ref37', 'doi-asserted-by': 'publisher', 'DOI': '10.1039/c2fo10254d'},
{'key': 'ref38', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2918-0'},
{'key': 'ref39', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijtb.2020.09.031'},
{'key': 'ref40', 'doi-asserted-by': 'publisher', 'DOI': '10.1055/s-0040-1715798'},
{'key': 'ref41', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/dth.13476'},
{'key': 'ref42', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/mnfr.201700447'},
{ 'key': 'ref43',
'first-page': '275',
'article-title': 'Safety of quercetin for clinical application',
'volume': '16',
'author': 'Okamoto',
'year': '2005',
'journal-title': 'Int. J. Mol. Med.'},
{'key': 'ref44', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.yrtph.2018.03.019'},
{'key': 'ref45', 'doi-asserted-by': 'publisher', 'DOI': '10.2903/j.efsa.2018.5239'},
{'key': 'ref46', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jtcme.2020.12.001'},
{'key': 'ref47', 'doi-asserted-by': 'publisher', 'DOI': '10.1055/s-0043-100934'},
{'key': 'ref48', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ejphar.2021.174615'},
{'key': 'ref49', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41590-021-01114-w'},
{'key': 'ref50', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphar.2021.716672'},
{'key': 'ref51', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.taap.2018.06.022'},
{'key': 'ref52', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2020.590716'},
{'key': 'ref53', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules26051200'}],
'container-title': 'International Journal of Translational Medicine',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/2673-8937/2/2/22/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 6, 17]],
'date-time': '2022-06-17T07:08:20Z',
'timestamp': 1655449700000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/2673-8937/2/2/22'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 6, 16]]},
'references-count': 53,
'journal-issue': {'issue': '2', 'published-online': {'date-parts': [[2022, 6]]}},
'alternative-id': ['ijtm2020022'],
'URL': 'http://dx.doi.org/10.3390/ijtm2020022',
'relation': {},
'ISSN': ['2673-8937'],
'container-title-short': 'IJTM',
'published': {'date-parts': [[2022, 6, 16]]}}
